These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 87047)

  • 21. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating antibodies in rats bearing grafted colon carcinoma.
    Martin F; Martin M; Lagneau A; Bordes M; Knobel S
    Cancer Res; 1976 Sep; 36(9 pt.1):3039-42. PubMed ID: 61808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescent antibody studies in malignant melanoma.
    Whitehead RH
    Br J Cancer; 1973 Dec; 28(6):525-9. PubMed ID: 4205845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
    Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
    J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
    Howell JH; Russo AJ; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):612-8. PubMed ID: 83914
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum.
    Schultz RM; Woods WA; Chirigos MA
    Int J Cancer; 1975 Jul; 16(1):16-23. PubMed ID: 51831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigens on human tumor cells assayed by complement fixation with allogeneic sera.
    Gupta RK; Irie RF; Morton DL
    Cancer Res; 1978 Aug; 38(8):2573-80. PubMed ID: 78763
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
    Ferrone S; Pellegrino MA
    J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural antibodies in human sera directed against blood-group-related determinants expressed on colon cancer cells.
    Knuth A; Lloyd KO; Lipkin M; Oettgen HF; Old LJ
    Int J Cancer; 1983 Aug; 32(2):199-204. PubMed ID: 6192101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. II. Immunobiologic characterization.
    Gupta RK; Morton DL
    J Natl Cancer Inst; 1984 Jan; 72(1):75-82. PubMed ID: 6582305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
    Hollinshead AC
    Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mixed hemadsorption assay for detection of cell surface binding anti-tumor antibodies in human sera.
    Akis N; Andl C; Zhou D
    J Immunol Methods; 2002 Mar; 261(1-2):119-27. PubMed ID: 11861070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.
    Mattes MJ; Thomson TM; Old LJ; Lloyd KO
    Int J Cancer; 1983 Dec; 32(6):717-21. PubMed ID: 6197381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
    Carey TE; Takahashi T; Resnick LA; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3278-82. PubMed ID: 1067619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines.
    Livingston PO; Kaelin K; Pinsky CM; Oettgen HF; Old LJ
    Cancer; 1985 Nov; 56(9):2194-200. PubMed ID: 4052966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo.
    Galbraith GM; Miller D; Emerson DL
    Clin Immunol Immunopathol; 1988 Sep; 48(3):317-24. PubMed ID: 3042212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-dependent serum cytotoxicity of cancer patients studied by 51Cr release assay on human cancer lines.
    Puche JG; Canevari S; Fossati G; Porta GD; Vezzoni P
    Tumori; 1977; 63(1):97-108. PubMed ID: 878026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.
    Shiku H; Takahashi T; Oettgen HF
    J Exp Med; 1976 Oct; 144(4):873-81. PubMed ID: 978138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.